Pre-publication history
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study
BMC Pharmacology and Toxicology 2013, 14:1 doi:10.1186/2050-6511-14-1
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 21 Mar 2012 | |
| Reviewer's Report | Zaheer Babar | 07 May 2012 | |
| Reviewer's Report | Atholl Johnston | 01 Jun 2012 | |
| Reviewer's Report | Brian Godman | 07 Jun 2012 | |
| Reviewer's Report | Brian Godman | 07 Jun 2012 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 31 Aug 2012 |
| Reviewer's Report | Brian Godman | 05 Oct 2012 | |
| Reviewer's Report | Atholl Johnston | 05 Oct 2012 | |
| Reviewer's Report | Zaheer Babar | 11 Oct 2012 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 20 Nov 2012 |
| Resubmission - Version 4 | Manuscript | 14 Dec 2012 | |
| Resubmission - Version 5 | Manuscript | Author's comment | 22 Dec 2012 |
| Editorial acceptance | 24 Dec 2012 | ||
| Published | 05 Jan 2013 |
